Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Can you please post link to that, I can’t find it at the moment
I’ve been going through all of them again, and I actually can’t find it. It wasn’t mentioning APL specifically but it said something like - new management won’t proceed until all liabilities are settled - or something like that...I really could have sworn I saw something somewhere that said they weren’t moving forward until it was squared away...and I can’t find it.....I apologize to all and any who read my previous post, I can’t find the document to back it up....mods feel free to delete my previous post about amended filings having that wording in there. My apologies again.
But they amended the filings to specifically state that APL won’t move forward until it is resolved...
This is not good man...why aren’t they cooperating?
I’m been one of the longest longs here, please don’t anyone call me a basher for asking.
https://unicourt.com/case/urc-GFGCAJBWI44FCHI5N44XBC3QMNKBQ0927#dockets
NEWS
Regen BioPharma Successfully Treats Rheumatoid Arthritis Using Cannabidiol (CBD) Based Immune Modulatory Treatments
Company Develops Novel T Regulatory Cell Activating Approach Potentially Useful for Diverse Autoimmune and Inflammatory Diseases
SAN DIEGO, Oct. 3, 2019 /PRNewswire/ -- Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP), announced today positive data demonstrating that its novel cannabidiol-based therapeutic approach successfully reduces rheumatoid arthritis in an animal model. The data disclosed today, which is the subject of a United States patent application, show that the Company's drug candidate induces activation of a type of immune system cell termed "T Regulatory Cells". The immunology community believes that T regulatory cells serve a fundamental role in protecting the body from uncontrolled inflammation or autoimmunity[1].
"The reduction of rheumatoid arthritis disease, which correlated with an increase in T regulatory cell numbers and a decrease in Th17 cells induced by the cannabidiol-based therapeutic drug mimics natural conditions in which autoimmunity goes into remission," said Thomas Ichim, PhD, Senior Advisor to the Company. "Similar changes in immunological parameters are seen in pregnancy, in which various autoimmune diseases are known to go into remission[2]. We believe that we may have uncovered a new approach to autoimmunity that spares the patients the toxicity and side effects of non-specific immune suppression, which is the current treatment paradigm today."
Autoimmune diseases are conditions in which the immune system starts attacking components of the body. Major autoimmune conditions include rheumatoid arthritis, multiple sclerosis, type 1 diabetes, and lupus.
"These current findings add another therapeutic candidate to our existing portfolio which centers of modulation of inflammatory pathways such as NR2F6," noted David Koos, Chairman and CEO of Regen BioPharma. "What this means to our small molecule drug development programs is CBD appears when used with other compounds to amplify the desired outcome. Our current pipeline of NR2F6 small molecules both augment and inhibit interleukin-17 production, we see potential synergy between today's disclosed data and our ongoing small molecule programs."
About Regen BioPharma Inc.:
Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.
Disclaimer: This news announcement may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
CONTACT INFORMATION
Regen BioPharma Inc.
David R. Koos, Ph.D.
Chairman & Chief Executive Officer
+1-619-702-1404 Phone
+1-619-330-2328 Fax
http://www.regenbiopharma.com
david.koos@regenbiopharma.com
[1] Göschl et al. Treg cells in autoimmunity: from identification to Treg-based therapies. Semin Immunopathol. 2019 May;41(3):301-314. https://link.springer.com/article/10.1007%2Fs00281-019-00741-8
[2] https://www.sciencedaily.com/releases/2010/06/100617102406.htm
https://c212.net/c/img/favicon.png?sn=IO92514&sd=2019-10-03 View original content:http://www.prnewswire.com/news-releases/regen-biopharma-successfully-treats-rheumatoid-arthritis-using-cannabidiol-cbd-based-immune-modulatory-treatments-300930351.html
SOURCE Regen BioPharma Inc.
Glad I sold out this morning.
I agree, the holy grail should sell itself. I also agree they should have itemized liabilities.
Def have a lot more digging to do tomorrow. Will try and find results if previous projects. Will share what I find.
Do you think it could have just been almost like the proof of concept phase? 2017 had high expenses as well....now 2019 barely anything in comparison....seems once they finished/ completed and proved concept they aggressively got the word out to the world? How do you view and interpret such a drastic change in those particular expenses?
Now they have improved the design, cost efficiencies drastically reduced - (as per website... & I believe it is a few years old) I would think that it will be a much more attractive option, with the previous projects proving it worked, the next gen tech being twice as efficient, and they just got the grant which put this on a lot more radars.
Also, they don’t just sell the equipment, they offer as a service as well.
“Rainmaker technology is available either as a capital purchase, or on a Water-As-A-Service basis. This flexibility meets the needs of various governments, corporations and organizations”
The second-generation units have improved energy efficiency by as much as 100%, significantly reducing the cost of each liter of water produced. The units are approximately 50% more energy efficient than those of our competitors.
Rainmaker Worldwide Inc. was formed in Peterborough, Ontario, Canada in 2014 to consolidate all assets, intellectual property, and the executive management expertise of Dutch Rainmaker.
Round 1 financing was completed December 2015. The first full year of operation was 2016.
But I’m not sure yet, I have a lot more digging to do. The CEO seems like a real player though, serious money kinda guy. I want to try and find out how those other projects went though, and the numbers they generated in regards to energy cost/ consumption compared to water output...if there were any problems or issues they encountered, if so what measures have they taken to improve or correct, etc.
I’m assuming they went very well though being that THEY were just given this grant. But I still want to see for myself.
Little nervous because board is so quiet other than what it appears to be hardcore pumping front loaders.
But I’m going to keep trying to learn more. If these projects really start to pick up and tech continues to deliver and improve....i really don’t see any reason for this not to become a multi billion dollar company over the coming years.
Still a lot to learn though, happy to hear any honest thoughts from those with more experience.
So roughly $13,000 dollars from over 10 years ago equates to $4 MILLION dollars in shares getting dumped on us today?
Do you have any thoughts on the grant they were just awarded?
https://www.otcmarkets.com/stock/RAKR/news/Rainmaker-Worldwide-Inc-OTC-RAKR-Wins-EU-Horizon-2020-Project-and-Awarded-25Mil-USD-Grant-to-Develop-First-of-Its-Kind-1?id=241773
The minute it starts to gain some momentum...The wall goes up to walk it back down....gotta love it!
Amended filings out
Hell yeah Apostle!
Third it!
You don’t think it is just a precaution/ safety measure to be used only if needed in the event of an attempted hostile takeover?
362m O/S. 114m company.
.3149/PPS
Starting point 6x from here?
Lol....guess not to well :-/
Back in the party!
Yes sir! Can’t wait for the fireworks to begin!!!
Dif* ticker....should prolly go back and edit before I hit send, stupid auto correct on phone!
Live* by it
Love my life by it buddy. But I am the wrong guy to ask, and I don’t have pm and ain’t gunna promote a dog ticket on this glorious board!
Sold this morning @ 1.50 and just doubled my position. Let’s see how far off the falling knife I was!
https://www.cbc.ca/news/canada/north/quest-rare-minerals-mou-lockheed-martin-airships-1.3860871
....supposed to be done this year.
Let’s see what happens!
You give me a good laugh dude...not even kidding either
The market cap was close to 1b on that bitch yesterday, sold out at 1.50 from .40s....wonder where I’m gunna park that money next ...hmmmm
Life’s a bitch! We live and we learn! Best of luck pal! And to all others here as well!
Go HMLA!
Dude....I was in a group chat where supposedly JC himself was in it and removed himself from it the instant that ticker came up....I was there subvpenny before the market makers gapped it up....and I passed like a total rookie who had no idea what he was looking at, passed at 5, 13s...finally bought at .40......would have changed my life man. Learned a valuable lesson there though....thought 1300% was up to much and I already missed it...now that we just got that confirmation from sticky....I am loading the god damn boat!!! More like a dingy, but hey! I’ll get there!!!!
Wow...I totally thought it was a fake username. Thank you for posting that. Wish I didn’t sell. Praying for a pullback but I will slap silly if need be lol
The one month just crossed. Let’s see what happens!
Loser of the week goes tocme on this one lol...bought .018 and sold .025....guess that’s why I still have my day job! Best of luck folks!
This is Robert Xu shells, DC*D is Justin Costello....other one isn’t confirmed...
Time for reversal?
Probably going to get crucified for this but...I’m just not seeing it, where is the connection? Bought Friday and sold today for full disclosure....dug over weekend and just couldn’t find it. Could very well be that it is simply beyond my scope of DD capabilities, but again...found diddly squat! ...anyone find anything concrete??? TIA
Same here!
I get that, but i feel like there really weren’t that many shares traded under .01 compared to average daily volume, so any of those guys selling end of day at those prices Friday was taking a loss or at best breaking even. But yea, totally agree about the volatility, I let go of a few myself today. Excited to see how this one pans out!
....just my take on it. Happy to hear anyone else’s opinion as well!
At the end of the day Friday it seemed like someone just wanted to completely unload what they had left, filled a bunch of bids at .01 and .0125 in the last 15-20 mins....thought it might have just been flippers wanting beer money for the weekend....you think it could have been dilution?
Almost regret selling 1/3 for a 300% profit right now. Riding the freebies feels good though
Waiting for beer flippers to slap my 50k bid lol